3. Umbruch 4.4..2005 - Online Pot

More documents

Recommendations

Info

Cannabinoid chemistry: an overview 35 Structure 13 Recently the discovery of a further class of diarylpyrazolines with high potency and selectivity for the CB 1 receptor was described [103]. These compounds were found to be CB 1 antagonists. SLV319 was found to be a potent CB 1 antagonist (K i = 7.8 nM) close to that of the Sanofi compound SR-141716A, with more than 1000-fold selectivity against CB 2. Structure 14 Additional synthetic compounds that bind to the CB 1 and/or CB 2 receptors have been mentioned in patents. These were recently reviewed by Hertzog [104].
Page 2:
(( 3. Umbruch 4.4..2005 ))
Page 6:
Cannabinoids as Therapeutics Edited
Page 10:
Contents List of contributors . . .
Page 14:
List of contributors Itai A. Bab, B
Page 18:
Preface Twenty years ago the endoca
Page 22:
Page 26:
Cannabis in India: ancient lore and
Page 30:
Page 34:
Page 38: Cannabis in India: ancient lore and
Page 66: Cannabinoids as Therapeutics Edited
Page 70: Cannabinoid chemistry: an overview
Page 92: 36 L.O. Hanusˇ and R. Mechoulam No
Page 96: 38 L.O. Hanusˇ and R. Mechoulam St
Page 100: 40 L.O. Hanusˇ and R. Mechoulam St
Page 104: 42 L.O. Hanusˇ and R. Mechoulam of
Page 108: 44 L.O. Hanusˇ and R. Mechoulam Ku
Page 112: 46 M. Maccarrone 117 Huffman JW, Ze
Page 116: 48 R.G. Pertwee ed that, in contras
Page 120: 50 R.G. Pertwee rats and mice at do
Page 124: 52 R.G. Pertwee prevent petit mal e
Page 128: 54 R.G. Pertwee Neurotoxicity As di
Page 132: 56 R.G. Pertwee Table 3. Anti-infla
Page 136: 58 R.G. Pertwee followed by sleep,
Page 140:
60 R.G. Pertwee or cancer against w
Page 144:
62 R.G. Pertwee cannabidiol with ph
Page 148:
64 R.G. Pertwee choactivity. In: DJ
Page 152:
Page 156:
Endocannabinoids and regulation of
Page 160:
Page 164:
Page 168:
Page 172:
Page 176:
Page 180:
Cannabinoids in neurodegeneration a
Page 184:
Page 188:
Page 192:
Page 196:
Page 200:
Page 204:
Page 208:
Page 212:
Page 216:
Page 220:
Page 224:
Page 228:
Page 232:
Page 236:
Page 240:
112 S.A. Varvel and A.H. Lichtman a
Page 244:
114 S.A. Varvel and A.H. Lichtman T
Page 248:
116 S.A. Varvel and A.H. Lichtman c
Page 252:
118 S.A. Varvel and A.H. Lichtman A
Page 256:
120 S.A. Varvel and A.H. Lichtman T
Page 260:
122 S.A. Varvel and A.H. Lichtman p
Page 264:
124 S.A. Varvel and A.H. Lichtman n
Page 268:
126 S.A. Varvel and A.H. Lichtman e
Page 272:
128 S.A. Varvel and A.H. Lichtman m
Page 276:
130 S.A. Varvel and A.H. Lichtman b
Page 280:
132 S.A. Varvel and A.H. Lichtman C
Page 284:
134 S.A. Varvel and A.H. Lichtman a
Page 288:
136 S.A. Varvel and A.H. Lichtman 8
Page 292:
138 S.A. Varvel and A.H. Lichtman u
Page 296:
140 S.A. Varvel and A.H. Lichtman d
Page 300:
142 R.E. Musty Since the discovery
Page 304:
144 R.E. Musty effects. Low doses s
Page 308:
146 R.E. Musty Discussion The data
Page 312:
Page 316:
Cannabinoid targets for pain therap
Page 320:
Page 324:
Page 328:
Page 332:
Page 336:
Page 340:
Page 344:
Page 348:
Potential use of cannabimimetics in
Page 352:
Page 356:
Page 360:
Page 364:
Page 368:
Page 372:
Page 376:
Page 380:
184 L.A. Parker et al. 5-HT 3 antag
Page 384:
186 L.A. Parker et al. ing nausea,
Page 388:
188 L.A. Parker et al. Cats and dog
Page 392:
190 L.A. Parker et al. [27] indicat
Page 396:
192 L.A. Parker et al. Anecdotal ev
Page 400:
194 L.A. Parker et al. specific to
Page 404:
196 L.A. Parker et al. References 1
Page 408:
198 L.A. Parker et al. 45 Mechoulam
Page 412:
200 L.A. Parker et al. norvegicus d
Page 416:
202 I.A. Bab signaling [20, 21] as
Page 420:
204 I.A. Bab cular and cellular bio
Page 424:
206 I.A. Bab 39 Iuliano-Burns S, Mi
Page 428:
208 D. Parolaro and T. Rubino (Amer
Page 432:
210 D. Parolaro and T. Rubino addic
Page 436:
212 D. Parolaro and T. Rubino Condi
Page 440:
214 D. Parolaro and T. Rubino plete
Page 444:
216 D. Parolaro and T. Rubino prote
Page 448:
218 D. Parolaro and T. Rubino Exp T
Page 452:
220 F. Barth and M. Rinaldi-Carmona
Page 456:
Page 460:
Page 464:
Page 468:
Page 472:
Page 476:
232 G.W. Guy and C.G. Stott However
Page 480:
234 G.W. Guy and C.G. Stott In the
Page 484:
236 G.W. Guy and C.G. Stott ∆ 9 -
Page 488:
238 G.W. Guy and C.G. Stott Figure
Page 492:
240 G.W. Guy and C.G. Stott For the
Page 496:
Page 500:
244 G.W. Guy and C.G. Stott oxide,
Page 504:
246 G.W. Guy and C.G. Stott Ireland
Page 508:
Page 512:
Page 516:
252 G.W. Guy and C.G. Stott Table 2
Page 520:
254 G.W. Guy and C.G. Stott of the
Page 524:
256 G.W. Guy and C.G. Stott reactio
Page 528:
Page 532:
260 G.W. Guy and C.G. Stott easily
Page 536:
262 G.W. Guy and C.G. Stott 40 Walt
Page 540:
Index AA-5-HT 156 absent-mindedness
Page 544:
Index 267 cannabinoid agonist 190,
Page 548:
Index 269 HU-210 93, 95, 142, 153,
Page 552:
Index 271 oxidative cell death 84 o
show all

3. Umbruch 4.4..2005 - Online Pot

Create successful ePaper yourself

Delete template?

Save as template?